Page last updated: 2024-10-28

haloperidol and Drug-Induced Stevens Johnson Syndrome

haloperidol has been researched along with Drug-Induced Stevens Johnson Syndrome in 1 studies

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, SC1
Tsai, SJ1

Other Studies

1 other study available for haloperidol and Drug-Induced Stevens Johnson Syndrome

ArticleYear
Hyponatremia and Stevens-Johnson syndrome in a patient receiving carbamazepine.
    General hospital psychiatry, 1995, Volume: 17, Issue:6

    Topics: Adult; Carbamazepine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy,

1995